Financhill
Buy
58

TXN Quote, Financials, Valuation and Earnings

Last price:
$165.50
Seasonality move :
0.9%
Day range:
$161.90 - $165.52
52-week range:
$139.95 - $220.39
Dividend yield:
3.27%
P/E ratio:
31.27x
P/S ratio:
9.43x
P/B ratio:
9.13x
Volume:
5.2M
Avg. volume:
9.7M
1-year change:
-9.79%
Market cap:
$149.7B
Revenue:
$15.6B
EPS (TTM):
$5.27
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $14.5B $18.3B $20B $17.5B $15.6B
Revenue Growth (YoY) 0.54% 26.85% 9.18% -12.53% -10.72%
 
Cost of Revenues $5.2B $6B $6.3B $6.5B $6.5B
Gross Profit $9.3B $12.4B $13.8B $11B $9.1B
Gross Profit Margin 64.1% 67.47% 68.76% 62.9% 58.14%
 
R&D Expenses $1.5B $1.6B $1.7B $1.9B $2B
Selling, General & Admin $1.6B $1.7B $1.7B $1.8B $1.8B
Other Inc / (Exp) $91M -$53M -$151M $440M $620M
Operating Expenses $3.2B $3.2B $3.4B $3.7B $3.8B
Operating Income $6.1B $9.2B $10.4B $7.3B $5.3B
 
Net Interest Expenses $190M $184M $214M $353M $508M
EBT. Incl. Unusual Items $6B $8.9B $10B $7.4B $5.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $422M $1.2B $1.3B $908M $654M
Net Income to Company $5.6B $7.8B $8.7B $6.5B $4.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.6B $7.8B $8.7B $6.5B $4.8B
 
Basic EPS (Cont. Ops) $6.05 $8.38 $9.51 $7.13 $5.24
Diluted EPS (Cont. Ops) $5.97 $8.26 $9.41 $7.07 $5.20
Weighted Average Basic Share $921M $923M $916M $908M $912M
Weighted Average Diluted Share $933M $936M $926M $916M $919M
 
EBITDA $7.2B $10.1B $11.2B $9B $7.5B
EBIT $6.2B $9.1B $10.2B $7.8B $6B
 
Revenue (Reported) $14.5B $18.3B $20B $17.5B $15.6B
Operating Income (Reported) $6.1B $9.2B $10.4B $7.3B $5.3B
Operating Income (Adjusted) $6.2B $9.1B $10.2B $7.8B $6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $4.3B $4.9B $4.4B $3.7B $4.1B
Revenue Growth (YoY) 28.84% 14.36% -10.72% -16.4% 11.15%
 
Cost of Revenues $1.5B $1.5B $1.5B $1.6B $1.8B
Gross Profit $2.8B $3.4B $2.9B $2.1B $2.3B
Gross Profit Margin 65.21% 70.17% 65.38% 57.23% 56.84%
 
R&D Expenses $386M $391M $455M $478M $517M
Selling, General & Admin $425M $422M $474M $455M $472M
Other Inc / (Exp) -$1M -$51M $80M $247M $80M
Operating Expenses $811M $813M $929M $933M $989M
Operating Income $2B $2.6B $1.9B $1.2B $1.3B
 
Net Interest Expenses $46M $52M $68M $116M $128M
EBT. Incl. Unusual Items $1.9B $2.5B $1.9B $1.3B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $186M $325M $238M $188M $97M
Net Income to Company $1.8B $2.2B $1.7B $1.1B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $2.2B $1.7B $1.1B $1.2B
 
Basic EPS (Cont. Ops) $1.89 $2.37 $1.87 $1.21 $1.29
Diluted EPS (Cont. Ops) $1.87 $2.35 $1.85 $1.20 $1.28
Weighted Average Basic Share $922M $923M $907M $910M $910M
Weighted Average Diluted Share $935M $934M $916M $917M $916M
 
EBITDA $2.2B $2.8B $2.3B $1.8B $1.8B
EBIT $2B $2.6B $2B $1.4B $1.4B
 
Revenue (Reported) $4.3B $4.9B $4.4B $3.7B $4.1B
Operating Income (Reported) $2B $2.6B $1.9B $1.2B $1.3B
Operating Income (Adjusted) $2B $2.6B $2B $1.4B $1.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $15.4B $19B $19.5B $16.8B $16B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.4B $5.9B $6.3B $6.6B $6.7B
Gross Profit $10B $13B $13.2B $10.3B $9.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.5B $1.6B $1.7B $1.9B $2B
Selling, General & Admin $1.6B $1.7B $1.8B $1.8B $1.8B
Other Inc / (Exp) $115M -$103M -$20M $607M $453M
Operating Expenses $3.2B $3.2B $3.5B $3.7B $3.8B
Operating Income $6.8B $9.8B $9.7B $6.6B $5.5B
 
Net Interest Expenses $191M $190M $230M $401M $520M
EBT. Incl. Unusual Items $6.7B $9.5B $9.5B $6.8B $5.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $558M $1.3B $1.2B $858M $563M
Net Income to Company $6.2B $8.2B $8.3B $5.9B $4.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.2B $8.2B $8.3B $5.9B $4.9B
 
Basic EPS (Cont. Ops) $6.70 $8.86 $9.02 $6.48 $5.32
Diluted EPS (Cont. Ops) $6.60 $8.74 $8.90 $6.41 $5.27
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $7.9B $10.6B $10.7B $8.5B $7.6B
EBIT $6.9B $9.7B $9.7B $7.2B $6B
 
Revenue (Reported) $15.4B $19B $19.5B $16.8B $16B
Operating Income (Reported) $6.8B $9.8B $9.7B $6.6B $5.5B
Operating Income (Adjusted) $6.9B $9.7B $9.7B $7.2B $6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $4.3B $4.9B $4.4B $3.7B $4.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5B $1.5B $1.5B $1.6B $1.8B
Gross Profit $2.8B $3.4B $2.9B $2.1B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $386M $391M $455M $478M $517M
Selling, General & Admin $425M $422M $474M $455M $472M
Other Inc / (Exp) -$1M -$51M $80M $247M $80M
Operating Expenses $811M $813M $929M $933M $989M
Operating Income $2B $2.6B $1.9B $1.2B $1.3B
 
Net Interest Expenses $46M $52M $68M $116M $128M
EBT. Incl. Unusual Items $1.9B $2.5B $1.9B $1.3B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $186M $325M $238M $188M $97M
Net Income to Company $1.8B $2.2B $1.7B $1.1B $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $2.2B $1.7B $1.1B $1.2B
 
Basic EPS (Cont. Ops) $1.89 $2.37 $1.87 $1.21 $1.29
Diluted EPS (Cont. Ops) $1.87 $2.35 $1.85 $1.20 $1.28
Weighted Average Basic Share $922M $923M $907M $910M $910M
Weighted Average Diluted Share $935M $934M $916M $917M $916M
 
EBITDA $2.2B $2.8B $2.3B $1.8B $1.8B
EBIT $2B $2.6B $2B $1.4B $1.4B
 
Revenue (Reported) $4.3B $4.9B $4.4B $3.7B $4.1B
Operating Income (Reported) $2B $2.6B $1.9B $1.2B $1.3B
Operating Income (Adjusted) $2B $2.6B $2B $1.4B $1.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.1B $4.6B $3.1B $3B $3.2B
Short Term Investments $3.5B $5.1B $6B $5.6B $4.4B
Accounts Receivable, Net $1.4B $1.7B $1.9B $1.8B $1.7B
Inventory $2B $1.9B $2.8B $4B $4.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $302M $335M $302M $761M $1.2B
Total Current Assets $10.2B $13.7B $14B $15.1B $15B
 
Property Plant And Equipment $3.3B $5.1B $6.9B $10B $11.3B
Long-Term Investments -- -- -- -- --
Goodwill $4.4B $4.4B $4.4B $4.4B $4.4B
Other Intangibles $122M $85M $152M $223M $257M
Other Long-Term Assets $770M $748M $740M $1.7B $3.3B
Total Assets $19.4B $24.7B $27.2B $32.3B $35.5B
 
Accounts Payable $415M $571M $851M $802M $820M
Accrued Expenses $524M $82M $191M $341M $352M
Current Portion Of Long-Term Debt $550M $500M $500M $599M $750M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $520M $455M $570M $723M
Total Current Liabilities $2.4B $2.6B $3B $3.3B $3.6B
 
Long-Term Debt $6.2B $7.2B $8.2B $10.6B $12.8B
Capital Leases -- -- -- -- --
Total Liabilities $10.2B $11.3B $12.6B $15.5B $18.6B
 
Common Stock $1.7B $1.7B $1.7B $1.7B $1.7B
Other Common Equity Adj -$360M -$157M -$254M -$205M -$140M
Common Equity $9.2B $13.3B $14.6B $16.9B $16.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $9.2B $13.3B $14.6B $16.9B $16.9B
 
Total Liabilities and Equity $19.4B $24.7B $27.2B $32.3B $35.5B
Cash and Short Terms $6.6B $9.7B $9.1B $8.6B $7.6B
Total Debt $6.8B $7.7B $8.7B $11.2B $13.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.4B $3.5B $4.5B $2.5B $2.8B
Short Term Investments $4.2B $6.3B $5.1B $7.9B $2.2B
Accounts Receivable, Net $1.6B $1.8B $1.9B $1.7B $1.9B
Inventory $1.9B $2.1B $3.3B $4.1B $4.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $245M $330M $313M $302M $339M
Total Current Assets $10.4B $14B $15B $17.4B $13.1B
 
Property Plant And Equipment $3.4B $5.4B $7.7B $10.4B $11.8B
Long-Term Investments -- -- -- -- --
Goodwill $4.4B $4.4B $4.4B $4.4B $4.4B
Other Intangibles $218M $91M $140M $231M $263M
Other Long-Term Assets $657M $718M $1.4B $914M $1.1B
Total Assets $19.6B $25.3B $29.2B $34.9B $33.8B
 
Accounts Payable $567M $641M $952M $551M $866M
Accrued Expenses $467M $596M $686M $876M $921M
Current Portion Of Long-Term Debt -- $500M $500M $1.3B --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.7B $2.5B $2.9B $3.6B $2.5B
 
Long-Term Debt $6.3B $7.2B $9.6B $12.8B $12.8B
Capital Leases -- -- -- -- --
Total Liabilities $9.5B $11.3B $14B $17.9B $17.4B
 
Common Stock $1.7B $1.7B $1.7B $1.7B $1.7B
Other Common Equity Adj -$347M -$153M -$252M -$203M -$147M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $10.2B $14B $15.2B $17B $16.4B
 
Total Liabilities and Equity $19.6B $25.3B $29.2B $34.9B $33.8B
Cash and Short Terms $6.7B $9.8B $9.5B $10.4B $5B
Total Debt $6.3B $7.7B $10.1B $14.2B $12.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $5.6B $7.8B $8.7B $6.5B $4.8B
Depreciation & Amoritzation $992M $954M $979M $1.2B $1.6B
Stock-Based Compensation $224M $230M $289M $362M $387M
Change in Accounts Receivable -$340M -$287M -$194M $108M $68M
Change in Inventories $46M $45M -$847M -$1.2B -$528M
Cash From Operations $6.1B $8.8B $8.7B $6.4B $6.3B
 
Capital Expenditures $649M $2.5B $2.8B $5.1B $4.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$922M -$4.1B -$3.6B -$4.4B -$3.2B
 
Dividends Paid (Ex Special Dividend) -$3.4B -$3.9B -$4.3B -$4.6B -$4.8B
Special Dividend Paid
Long-Term Debt Issued $1.5B $1.5B $1.5B $3B $3B
Long-Term Debt Repaid -$500M -$550M -$500M -$500M -$600M
Repurchase of Common Stock -$2.6B -$527M -$3.6B -$293M -$929M
Other Financing Activities -$36M -$46M -$41M -$57M -$53M
Cash From Financing -$4.5B -$3.1B -$6.7B -$2.1B -$2.9B
 
Beginning Cash (CF) $2.4B $3.1B $4.6B $3.1B $3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $670M $1.5B -$1.6B -$86M $236M
Ending Cash (CF) $3.1B $4.6B $3.1B $3B $3.2B
 
Levered Free Cash Flow $5.5B $6.3B $5.9B $1.3B $1.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.8B $2.2B $1.7B $1.1B $1.2B
Depreciation & Amoritzation $241M $214M $281M $362M $444M
Stock-Based Compensation $61M $74M $104M $106M $116M
Change in Accounts Receivable -$170M -$94M $18M $116M -$141M
Change in Inventories $65M -$150M -$531M -$84M -$160M
Cash From Operations $1.9B $2.1B $1.2B $1B $849M
 
Capital Expenditures $308M $443M $982M $1.2B $1.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1B -$1.7B $28M -$3.3B $1.3B
 
Dividends Paid (Ex Special Dividend) -$940M -$1.1B -$1.1B -$1.2B -$1.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $1.4B $3B --
Long-Term Debt Repaid -$550M -- -- -- -$750M
Repurchase of Common Stock -$100M -$589M -$103M -$3M -$653M
Other Financing Activities -$12M -$7M -$15M -$28M -$16M
Cash From Financing -$1.4B -$1.6B $239M $1.8B -$2.5B
 
Beginning Cash (CF) $3.1B $4.6B $3.1B $3B $3.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$665M -$1.1B $1.4B -$481M -$437M
Ending Cash (CF) $2.4B $3.5B $4.5B $2.5B $2.8B
 
Levered Free Cash Flow $1.5B $1.7B $178M -$231M -$274M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $6.2B $8.2B $8.3B $5.9B $4.9B
Depreciation & Amoritzation $983M $927M $1B $1.3B $1.7B
Stock-Based Compensation $222M $243M $319M $364M $397M
Change in Accounts Receivable -$268M -$211M -$82M $206M -$189M
Change in Inventories $113M -$170M -$1.2B -$795M -$604M
Cash From Operations $7.1B $9.1B $7.7B $6.3B $6.2B
 
Capital Expenditures $796M $2.6B $3.3B $5.3B $4.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.9B -$4.7B -$1.9B -$7.7B $1.4B
 
Dividends Paid (Ex Special Dividend) -$3.5B -$4B -$4.4B -$4.6B -$4.9B
Special Dividend Paid
Long-Term Debt Issued -- -- $2.9B $4.6B --
Long-Term Debt Repaid -$1.1B -- -- -$500M -$1.4B
Repurchase of Common Stock -$1B -$1B -$3.1B -$193M -$1.6B
Other Financing Activities -$39M -$41M -$49M -$70M -$41M
Cash From Financing -$4.4B -$3.3B -$4.9B -$552M -$7.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$76M $1.1B $972M -$2B $280M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.3B $6.5B $4.4B $940M $1.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.8B $2.2B $1.7B $1.1B $1.2B
Depreciation & Amoritzation $241M $214M $281M $362M $444M
Stock-Based Compensation $61M $74M $104M $106M $116M
Change in Accounts Receivable -$170M -$94M $18M $116M -$141M
Change in Inventories $65M -$150M -$531M -$84M -$160M
Cash From Operations $1.9B $2.1B $1.2B $1B $849M
 
Capital Expenditures $308M $443M $982M $1.2B $1.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1B -$1.7B $28M -$3.3B $1.3B
 
Dividends Paid (Ex Special Dividend) -$940M -$1.1B -$1.1B -$1.2B -$1.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $1.4B $3B --
Long-Term Debt Repaid -$550M -- -- -- -$750M
Repurchase of Common Stock -$100M -$589M -$103M -$3M -$653M
Other Financing Activities -$12M -$7M -$15M -$28M -$16M
Cash From Financing -$1.4B -$1.6B $239M $1.8B -$2.5B
 
Beginning Cash (CF) $3.1B $4.6B $3.1B $3B $3.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$665M -$1.1B $1.4B -$481M -$437M
Ending Cash (CF) $2.4B $3.5B $4.5B $2.5B $2.8B
 
Levered Free Cash Flow $1.5B $1.7B $178M -$231M -$274M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 20.66% over the past day.

Buy
52
SRPT alert for May 8

Sarepta Therapeutics [SRPT] is up 2.18% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.75% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock